Todd G J, Nowygrod R, Benvenisty A, Buda J, Reemtsma K
Department of Surgery, Columbia-Presbyterian Medical Center, New York, NY 10032.
J Vasc Surg. 1991 Feb;13(2):302-10.
As CT scanning has evolved as a reliable clinical tool, the use of angiography in the diagnosis of aortic aneurysmal disease has diminished. Fewer than 25% of patients with aortic aneurysmal disease undergo aortic angiographic evaluation at our institution. A prospective clinical study was undertaken to assess the validity of this policy. One hundred patients with clinical or ultrasonographic evidence of aortic aneurysms were evaluated prospectively during the period July 1987 to December 1989. All patients underwent CT scanning as an initial evaluation. Patients were selected for angiography if they fulfilled any of the following criteria: radiographic evidence of thoracoabdominal or juxtarenal aneurysms, or horseshoe kidney; or clinical suggestion of renal artery stenosis, mesenteric arterial insufficiency, aortoiliac occlusive disease, or lower extremity aneurysmal disease. During this period 19 patients (19%) underwent both CT scanning and angiography. The indications for angiography were thoracoabdominal aneurysms (7), juxtarenal aneurysms (2), clinical evidence of mesenteric insufficiency (1) or renal insufficiency (2), evidence of lower extremity aneurysmal disease (3), or severe aortoiliac occlusive disease (4). Eighty-one patients (81%) underwent CT scanning as the only radiographic evaluation. No patient was adversely affected by elimination of angiographic evaluation. CT scanning revealed inflammatory aneurysms (4), retroaortic renal veins (2), and horseshoe kidney (1). This study suggests that most (81%) patients with aortic aneurysmal disease can be adequately evaluated by CT scanning, and that a very selective policy of angiographic evaluation is indicated.
随着CT扫描已发展成为一种可靠的临床工具,血管造影术在主动脉瘤疾病诊断中的应用已减少。在我们机构,接受主动脉瘤疾病治疗的患者中,接受主动脉血管造影评估的不到25%。我们进行了一项前瞻性临床研究,以评估该策略的有效性。在1987年7月至1989年12月期间,对100例有主动脉瘤临床或超声证据的患者进行了前瞻性评估。所有患者均接受CT扫描作为初始评估。如果患者符合以下任何标准,则选择进行血管造影:胸腹或肾旁动脉瘤的影像学证据,或马蹄肾;或肾动脉狭窄、肠系膜动脉供血不足、主髂动脉闭塞性疾病或下肢动脉瘤疾病的临床提示。在此期间,19例患者(19%)同时接受了CT扫描和血管造影。血管造影的指征包括胸腹动脉瘤(7例)、肾旁动脉瘤(2例)、肠系膜供血不足(1例)或肾功能不全(2例)的临床证据、下肢动脉瘤疾病(3例)或严重主髂动脉闭塞性疾病(4例)。81例患者(81%)仅接受CT扫描作为影像学评估。没有患者因取消血管造影评估而受到不利影响。CT扫描发现了炎性动脉瘤(4例)、主动脉后肾静脉(2例)和马蹄肾(1例)。这项研究表明,大多数(81%)主动脉瘤疾病患者可以通过CT扫描得到充分评估,并且表明需要采取非常有选择性的血管造影评估策略。